Caption Management, LLC Guardant Health, Inc. Transaction History

Caption Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $149,655 - $243,542	-6,711 Reduced 35.4%	12,248 $280,000
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $224,321 - $444,454	13,959 Added 279.18%	18,959 $547,000
Q1 2024 May 15, 2024	SELL	$17.13 - $26.91 $99,354 - $156,078	-5,800 Reduced 53.7%	5,000 $103,000
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $233,063 - $318,600	10,800 New	10,800 $292,000
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $1 Million - $1.48 Million	-43,745 Reduced 88.65%	5,600 $131,000
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $906,961 - $2.13 Million	35,651 Added 260.34%	49,345 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $3.6 Million - $5.03 Million	-82,486 Reduced 85.76%	13,694 $738,000
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $1.93 Million - $5.19 Million	67,090 Added 230.63%	96,180 $3.88 Million
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $1.4 Million - $2.92 Million	29,090 New	29,090 $1.93 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $3.12 Million - $4.69 Million	-52,834 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $3.14 Million - $4.37 Million	52,834 New	52,834 $4.13 Million

347

120M

793K

1.85M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.38B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.